Blue Jet Healthcare (BLUEJET) | Stock Overview & Key Data
Blue Jet Healthcare Performance Comparison
Stock Range
Today's Range
Low: ₹633.35
High: ₹656.20
on September 26, 2025
52 Week Range
Low: ₹463.70
High: ₹1,027.80
on October 31, 2024
on July 21, 2025
All-Time High: ₹1,027.80 on July 21, 2025
Explore how other Indian stocks compare to their 52-week ranges: View IN Market 52-Week Insights
Key Statistics
Market Cap
INR112.1B
EPS
20.65
P/E Ratio (TTM)
32.20
Forward P/E
40.69
P/B Ratio
10.17
PEG Ratio
0.23
Div. Yield
0.11%
ROE
26.93%
Beta
N/A
Debt to Equity
1.76
Financial Highlights
Profitability
Gross Margin
48.44%
Operating Margin
32.50%
Profit Margin
29.35%
Returns and Earnings
Return on Assets (TTM)
21.53%
Return on Equity (TTM)
26.93%
EBITDA
INR4.8B
Net Income (TTM)
INR3.6B
Growth
Revenue (TTM)
Revenue Per Share (TTM)
INR70.44
Quarterly Revenue Growth (YoY)
117.80%
Quarterly Earnings Growth (YoY)
141.30%
Dividend Information
Last 12-Month Dividend
₹1.00
Current Dividend Yield
0.11%
3-Year Average Dividend Yield
0.19%
3-Year Average Annual Dividend
₹0.33
3-Year Total Dividends
₹1.00
Ex-Dividend Date
September 17, 2024
Peer Performance Comparison
| Company | Market Cap | 1W | 1M | 3M | 6M | YTD | 1Y | 3Y | 5Y |
|---|---|---|---|---|---|---|---|---|---|
| Blue Jet Healthcare BLUEJET | 112.12B Mid-cap | -4.94% | -8.69% | -25.73% | -24.41% | 11.85% | 25.39% | 65.68% | 65.68% |
| Biocon BIOCON | 455.97B Large-cap | -8.21% | -5.41% | -3.31% | -2.70% | -8.11% | -8.12% | 16.48% | -25.13% |
| OneSource Specialty ONESOURCE | 207.35B Large-cap | -2.78% | -3.87% | -10.63% | 4.11% | 4.67% | 4.67% | 4.67% | 4.67% |
| Concord Biotech CONCORDBIO | 163.87B Mid-cap | -7.65% | -8.25% | -12.97% | -5.35% | -27.15% | -23.56% | 66.04% | 66.04% |
| Supriya Lifescience SUPRIYA | 56.60B Mid-cap | -3.33% | 6.68% | 3.14% | -5.54% | -7.20% | 24.45% | 133.96% | 45.13% |
| Dishman Carbogen DCAL | 44.90B Small-cap | -6.39% | 3.53% | 14.40% | 26.29% | -1.42% | 53.25% | 191.75% | 71.91% |
Ownership & Short Interest
Insider Ownership
86.00%
Institutional Ownership
0.60%
Shares Short
N/A
Short Ratio
N/A
Short % of Shares Outstanding
N/A
Average 10-Day Volume
828K
Average 90-Day Volume
700K
Recurring Investment / Dollar-Cost Averaging Calculator
Calculate how a regular investment in would have performed over time.
Note: This calculator is for informational purposes only and does not consider taxes, fees, or other costs associated with investing.
Frequently Asked Questions
- What is BLUEJET's 52-week high and low?
- In the last 52 weeks, Blue Jet Healthcare reached a high of ₹1,027.80 (on July 21, 2025) and a low of ₹463.70 (on October 31, 2024).
- What is the market cap and P/E ratio for BLUEJET?
- Curious about Blue Jet Healthcare's size and valuation? Its market capitalization stands at 112.12B. When it comes to valuation, the P/E ratio (trailing twelve months) is 32.20, and the forward P/E (looking ahead) is 40.69.
- Does BLUEJET pay dividends? If so, what's the yield?
- Yes, Blue Jet Healthcare is a dividend-paying stock. Investors have recently enjoyed a trailing annual dividend yield of 0.11%, and the company has paid an average of ₹0.33 per share annually over the past 3 years.
- Who are Blue Jet Healthcare's main competitors or similar companies to consider before investing?
When looking at Blue Jet Healthcare, it can be helpful to see how it compares to other players in its field. Here are a few similar companies or key competitors:
Company Mkt Cap Sector Industry 1Y Return 3Y Return Biocon
BIOCON455.97B Healthcare Biotechnology -8.12% 16.48% OneSource Specialty
ONESOURCE207.35B Healthcare Biotechnology 4.67% 4.67% Concord Biotech
CONCORDBIO163.87B Healthcare Biotechnology -23.56% 66.04% Supriya Lifescience
SUPRIYA56.60B Healthcare Biotechnology 24.45% 133.96% Dishman Carbogen
DCAL44.90B Healthcare Biotechnology 53.25% 191.75% For a more comprehensive list, please see the Peer Performance Comparison table on this page.
- What are the key financial health indicators for Blue Jet Healthcare Ltd.? (e.g., ROE, Debt/Equity)
- To get a sense of Blue Jet Healthcare's financial health, here are a few key indicators: its Return on Equity (ROE) over the last twelve months is 26.93%, the Debt to Equity ratio from the most recent quarter is 1.76, and its Gross Profit Margin stands at 48.44%.
- What is the recent revenue and earnings growth for BLUEJET?
- Looking at Blue Jet Healthcare's growth, its revenue over the trailing twelve months (TTM) was INR12B. Compared to the same quarter last year (YoY), quarterly revenue grew by 117.80%, and quarterly earnings saw a YoY growth of 141.30%.
- How much of BLUEJET stock is held by insiders and institutions?
- Wondering who owns Blue Jet Healthcare stock? Company insiders (like executives and directors) hold about 86.00% of the shares, while institutional investors (such as mutual funds and pension funds) own approximately 0.60%.
For more common questions about our data, please visit our About Data page.
Data is provided for informational purposes only. Devyara does not guarantee the accuracy of the data displayed.